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Abstract
Background: Spontaneous regression of metastatic renal cell carcinoma is rarely observed.
Case presentation: Metastatic renal cell carcinoma was identified in a 70-year-old male using
computed tomography-guided percutaneous needle biopsy. Two months after the diagnosis, a
partial resection of the sternal bone was performed. Pathological examination revealed granulated
tissue with bleeding and necrosis but no carcinogenic cells.
Conclusion: We report a pathologically identified case in which a sternal bone metastasis that was
noticed two years after radical nephrectomy regressed completely and spontaneously.
Background
Since the first reported case of spontaneous regression of
metastatic renal cell carcinoma in 1928 by Bumpus [1], it
has been known that renal cell carcinoma can regress
spontaneously, although the frequency of the phenome-
non was estimated to be less than 1%, and most cases
were observed after a resection of the primary tumor. The
site of the regression was most commonly in the lung. The
present case of spontaneous regression of metastasis from
renal cell carcinoma to the sternum is the first such case to
be reported.
Case presentation
A 70-year-old male was referred to our hospital with ante-
rior chest pain and a precordial mass in September 2004.
He had undergone right radical nephrectomy in July
2002, and renal cell carcinoma, T1aN0M0, stage I, had
been diagnosed. Medical follow-ups had been conducted
routinely without any treatment. In May 2004, after he
experienced anterior chest pain, computed tomography
(CT) was performed. This revealed in the sternum a low
density mass that gradually increased in size during the
following three months. In September 2004, there was an
8 × 7 cm mass, and destruction of some of the cortical
bone of the manubrium sterni had occurred, so a CT-
guided percutaneous needle biopsy was performed. (Fig.
1) The mass was composed of clear tumor cells arranged
in an alveolar configuration, and metastatic renal cell car-
cinoma was diagnosed histologically. (Fig. 2) We per-
formed distant metastasis check up and check his physical
function preparing for an operation. No evidence of other
distant metastases was seen. We took a chest CT prior to
the operation after an admission, the tumor shadow was
the same comparing with previous chest CT before the
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biopsy. The patient underwent a partial resection of the
sternal bone with wide margin including whole tumor tis-
sue in November 2004. The postoperative clinical course
was uneventful and the patient was discharged 11 days
later. Pathological examination revealed only granulation
tissue which composed of wide bleeding area and necrosis
area with strong infiltration of inflammatory cells espe-
cially for fibroblasts. The entire resected tissue specimen
was checked carefully, but no carcinoma cells were
detected. (Fig. 3) We judged that a complete, spontaneous
regression of metastatic renal cell carcinoma had taken
place. The patient's medical history was taken in minute
detail in relation to any kind of treatment for renal cell
carcinoma, but he had received no such treatment and
taken no medication, including alternative medicine, nor
had he consumed any "health foods" at any time during
the course of the disease. He is now receiving interferon
therapy and is in good condition without recurrence for
eight months after surgery.
Conclusion
Since Bumpus reported the first case of spontaneous
regression of metastatic renal cell carcinoma [1], the inci-
dence of spontaneous regression has been low, and is
thought to be less than 1% of all cases [2]. Challis and
Stam reviewed the spontaneous regression of cancer from
1900 to 1987, and found that renal cell carcinoma headed
the list of histologically diagnosed conditions that under-
went spontaneous regression [3].
The sites of regression observed in the reported cases
included the brain, bone and liver, but the highest inci-
dence was in the lung [4,5]. In most cases, the tumor
regressions were observed following treatments of the pri-
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mary tumors such as surgical removal, radiotherapy,
embolization and radio frequency ablation [4,6]. It is
reported that complete regression is even rarer than partial
regression. The duration of tumor regression is variable
and recrudescence is sometimes observed [5]. The mecha-
nism of spontaneous regression is still unclear, although
immunologic effects have been discussed.
In the present case, early-stage renal cell carcinoma was
diagnosed. The patient underwent no tumor-specific
treatment for about two years after the nephrectomy. The
size of the sternal tumor gradually increased until the per-
cutaneous needle biopsy was performed, but it regressed
completely within a mere two months. During these two
months, the patient had no chemotherapy or immuno-
therapy, or any kind of interventional treatment. Com-
plete regression of a metastatic tumor is quite rare
especially two years after the resection of the primary
tumor. One of the possible explanations of this phenom-
enon may in this case have been induced by the needle
biopsy performed in order to diagnose the metastasis; or
bleeding caused by the biopsy may have triggered a chain
reaction of host immune responses. The patient is now
receiving interferon therapy in our outpatient clinic on
individual basis rather than supported by literature data
to prevent recurrence of the tumor [7-9]. This is the first
reported case of spontaneous regression occurring in a
sternal bone metastasis from renal cell carcinoma.
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